The stock is moving higher as the broader market is experiencing gains, with the Nasdaq up 1.23%.Earnings SnapshotAcadia Healthcare reported fourth-quarter adjusted earnings of 7 cents, beating the consensus of 6 cents.Sales of $821.46 million, beating the consensus of $800.07 million. Revenue exceeded the high end of the company's implied fourth-quarter guidance, primarily a result of improved volume growth during the quarter.Performance MetricsSales increased 6.1% year-over-year. Same-facility revenue inc ...

Acadia Healthcare Company (NasdaqGS:ACHC) Q4 2025 Earnings call February 25, 2026 09:00 AM ET Speaker10Please note this event is being recorded. I would now like to turn the conference over to Mr. Patrick Feeley, Senior Vice President, Head of Investor Relations. Please go ahead, sir.Speaker11Thank you. Good morning. This morning, we issued a press release announcing our fourth quarter 2025 financial results. This press release can be found in the Investor Relations section of the acadiahealthcare.com websi ...

On February 17, 2026, Engine Capital Management reported selling 2,256,741 shares of Acadia Healthcare (NASDAQ:ACHC), an estimated $42.70 million trade based on quarterly average pricing. What happened According to a filing with the Securities and Exchange Commission dated February 17, 2026, Engine Capital Management reduced its position in Acadia Healthcare by 2,256,741 shares. The estimated transaction value was $42.70 million, calculated using the average closing price during the fourth quarter of 202 ...

Core Viewpoint - The fourth-quarter performance of U.S. small-cap equities showed modest gains, supported by a positive macroeconomic backdrop and attractive valuations, although the Aristotle Small Cap Equity Fund underperformed the Russell 2000 Index [1]. Company Performance - Acadia Healthcare Company, Inc. (NASDAQ: ACHC) was identified as a major performance detractor for the Aristotle Small Cap Equity Fund, with its stock closing at $16.77 per share on February 13, 2026, reflecting a one-month return of 43.58% but a significant decline of 59.16% over the past twelve months [2][3]. - The company reported mixed third-quarter earnings results, beating estimates but subsequently reducing forward guidance, which led to a sell-off in its stock [3]. Market Position and Hedge Fund Interest - Acadia Healthcare Company, Inc. is not among the 30 most popular stocks among hedge funds, with 40 hedge fund portfolios holding its shares at the end of the third quarter, a slight increase from 39 in the previous quarter [4]. - While the potential of Acadia Healthcare as an investment is acknowledged, the company is viewed as having less upside potential compared to certain AI stocks, which are considered to carry less downside risk [4].

Core Insights - Talkspace, a leading behavioral healthcare company, will release its fourth quarter and full year 2025 results on February 19, 2026, before market open, followed by a conference call at 8:30am ET [1] Company Overview - Talkspace (NASDAQ: TALK) is a prominent virtual behavioral healthcare provider focused on improving mental health access and quality [3] - The company offers a wide range of mental health services, including therapy for individuals, teens, and couples, as well as psychiatric treatment and medication management for adults [4] - Talkspace's services are accessible through a fully-encrypted web and mobile platform that complies with HIPAA and other regulatory requirements [5] Service Accessibility - Most Americans can access Talkspace services through health insurance plans, employee assistance programs, and partnerships with leading healthcare companies, or as a free benefit via employers, schools, or government agencies [5]

Group 1 - Acadia Healthcare Company Inc. (NASDAQ:ACHC) is considered a promising stock under $50, with Mizuho lowering its price target to $17 from $22 while maintaining a Neutral rating [1] - Mizuho identified 2026 as a pivotal year for the managed care and health facilities sector, suggesting recovery in margins across Commercial, Medicaid, and Medicare after a 3-year downturn [1] - Barclays analyst Andrew Mok reduced Acadia's price target to $14 from $17 following the company's third guidance cut of the year due to a $49 million increase in legal costs [2] Group 2 - RBC Capital adjusted its price target for Acadia Healthcare to $19 from $22, expressing disappointment over another reduction in financial guidance related to underestimated liability expenses [3] - Management at Acadia expects high professional and general liability costs to persist through 2026 [3] - Acadia Healthcare provides behavioral healthcare services in the US and Puerto Rico, but certain AI stocks are noted to offer greater upside potential with less downside risk [4]

Core Viewpoint - Acadia Healthcare Company, Inc. will participate in the 44th Annual J.P. Morgan Healthcare Conference scheduled for January 12-15, 2026, in San Francisco, California [1]. Group 1: Company Participation - The company will have an online webcast of its presentation available on its website starting at 5:15 p.m. Pacific Time on January 13, 2026 [1][2]. - A replay of the presentation will be accessible on the company's website for 30 days following the event [2]. Group 2: Company Overview - Acadia is a leading provider of behavioral healthcare services in the U.S., operating a network of 278 facilities with approximately 12,500 beds across 40 states and Puerto Rico as of September 30, 2025 [3]. - The company employs around 25,500 staff members and serves over 82,000 patients daily, making it the largest stand-alone behavioral healthcare company in the U.S. [3]. - Acadia offers a range of behavioral healthcare services in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics [3].

Core Insights - Engine Capital Management has initiated a new position in Acadia Healthcare, acquiring 2.6 million shares valued at $64 million, indicating a strategic investment in the behavioral health sector during a period of transition for the company [1][2]. Company Overview - Acadia Healthcare is a leading provider of behavioral healthcare services, operating hundreds of facilities across the U.S. and Puerto Rico, focusing on inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics [5][7]. - The company reported a total revenue of $3.3 billion and a net income of $107.4 million, with a market capitalization of $1.4 billion [4]. Financial Performance - Acadia Healthcare experienced a year-over-year revenue growth of 4.4%, reaching $851.6 million, alongside a 3.3% increase in same-facility admissions [9]. - However, the company has lowered its full-year revenue, EBITDA, and EPS guidance due to payor scrutiny, Medicaid softness, and increased liability costs, with adjusted EBITDA falling to $173 million from $194 million a year earlier [9]. Investment Rationale - The new position by Engine Capital represents 7.6% of its reportable assets under management as of September 30, suggesting a significant commitment to Acadia Healthcare [3]. - The stock price of Acadia Healthcare has decreased by 63% over the past year, underperforming the S&P 500, which has increased by 13% during the same period [3]. - Management is taking steps to improve financial performance by cutting 2026 capital expenditures by at least $300 million and aiming for positive free cash flow, which could enhance returns as new bed additions contribute to revenue [10].

Core Insights - Ethema Health Corporation will present at the Small Cap Growth Virtual Investor Conference on December 9th, 2025, with CEO Shawn Leon leading the presentation [1][2] - The company has entered into a Letter of Intent to acquire assets from Addiction Recovery Care LLC, which includes in-patient and out-patient facilities in Kentucky, with a total capacity of approximately 940 patients [4] - Ethema reported record revenue of $5.5 million for the third quarter, reflecting strong performance in its Florida and Kentucky operations [5] Company Developments - The acquisition of ARC assets includes a Mental Health Hospital, a Pharmacy, a Medical Laboratory, and a Rural Health Clinic, indicating a strategic expansion in the behavioral healthcare sector [4] - The company aims to develop world-class treatment programs for substance use disorders, leveraging its unique treatment style established over the past decade [6] Event Details - The virtual conference will allow real-time interaction between investors and the company, with opportunities for one-on-one meetings scheduled from December 9th to 14th [2][3] - An archived webcast will be available for those unable to attend the live event, ensuring broader access to the company's presentation [2]

Group 1 - Acadia Healthcare Company Inc. is considered a cheap stock to buy according to analysts, with KeyBanc lowering its price target to $30 from $35 while maintaining an Overweight rating [1][3] - In Q3 2025, Acadia Healthcare reported a revenue increase of 4.4%, totaling $851.6 million, supported by a 3% growth in same facility admissions [2][3] - The company's adjusted EBITDA for Q3 decreased to $173 million from $194.3 million in the prior year, leading to a reduction in Adjusted EBITDA guidance for 2025 to a range of $650 to $660 million [3]